Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: CaV2.3 calcium channel inhibition

MJFF awards $6m to Lario Therapeutics for Parkinson’s research

MJFF awards m to Lario Therapeutics for Parkinson’s research
p p Read More

The neurological disease is estimated to affect more than ten million people globally

July 23, 2024 CaV2.3 calcium channel inhibition, Michael J. Fox Foundation, neurodegenerative diseases, neurological conditions, News, Parkinson's disease
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy